Peregrine Capital Management’s Dentsply Sirona XRAY Stock Holding History

Peregrine Capital Management’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-260	Closed	-$13K	–	345
2022 Q1	$13K	Hold	260	–	–	﹤0.01%	311
2021 Q4	$15K	Hold	260	–	–	﹤0.01%	305
2021 Q3	$15K	Hold	260	–	–	﹤0.01%	303
2021 Q2	$16K	Hold	260	–	–	﹤0.01%	303
2021 Q1	$17K	Hold	260	–	–	﹤0.01%	309
2020 Q4	$14K	Hold	260	–	–	﹤0.01%	302
2020 Q3	$11K	Hold	260	–	–	﹤0.01%	321
2020 Q2	$11K	Hold	260	–	–	﹤0.01%	265
2020 Q1	$10K	Hold	260	–	–	﹤0.01%	264
2019 Q4	$15K	Hold	260	–	–	﹤0.01%	261
2019 Q3	$14K	Hold	260	–	–	﹤0.01%	253
2019 Q2	$15K	Hold	260	–	–	﹤0.01%	258
2019 Q1	$13K	Buy	+260	New	+$11.4K	﹤0.01%	257

Other funds holding XRAY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Peregrine Capital Management's XRAY Position: Q2 2022 in Review

Peregrine Capital Management sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 260 shares — an estimated $13K sold.

Peregrine Capital Management first reported a position in XRAY in Q1 2019 and held it in 13 quarters. The position peaked at $17K in Q1 2021. 470 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.

Peregrine Capital Management reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
Peregrine Capital Management sold 260 Dentsply Sirona shares in Q2 2022, an estimated $13K.
Peregrine Capital Management first reported a position in Dentsply Sirona in Q1 2019 and held it in 13 quarters.
Peregrine Capital Management's Dentsply Sirona position peaked at $17K in Q1 2021.
470 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.

Based on Peregrine Capital Management's 13F filing for Q2 2022, filed 20 Jul 2022.